Matarin Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MiMedx Group
MDXG
|
+$10.3M |
| 2 |
OneMain Financial
OMF
|
+$8.99M |
| 3 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$8.85M |
| 4 |
Protolabs
PRLB
|
+$8.64M |
| 5 |
MTOR
MERITOR, Inc.
MTOR
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MasTec
MTZ
|
+$14.6M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.16M |
| 3 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$7.88M |
| 4 |
Papa John's
PZZA
|
+$7.27M |
| 5 |
AHL
ASPEN Insurance Holding Limited
AHL
|
+$7.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.52% |
| 2 | Industrials | 14.47% |
| 3 | Technology | 13.37% |
| 4 | Consumer Discretionary | 12.24% |
| 5 | Healthcare | 10.95% |
Similar funds
Matarin Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Matarin Capital Management held 316 positions worth $1.18B, up 8.9% from $1.08B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $38.3M of net new capital in Q3 2017, opening 41 new positions and adding to 130 existing holdings. Its largest new stake was MiMedx Group: 694,135 shares worth $8.25M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Papa John's, an estimated $7.27M trimmed.
- Matarin Capital Management's largest Q3 2017 buy was MiMedx Group: 694,135 shares worth $8.25M.
- Matarin Capital Management added most to Protolabs in Q3 2017, an estimated $8.64M increase.
- Matarin Capital Management's biggest Q3 2017 reduction was Papa John's, cutting an estimated $7.27M.
- Matarin Capital Management fully exited MasTec in Q3 2017, selling an estimated $14.6M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.18B portfolio in Q3 2017.
- Matarin Capital Management opened 41 new positions and closed 25 in Q3 2017.
- Matarin Capital Management's portfolio value rose 8.9% quarter-over-quarter to $1.18B.
Based on Matarin Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.